Abstract:Spontaneous intracerebral hemorrhage (ICH) is a catastrophic illness causing significant morbidity and mortality. Despite advances in surgical technique addressing primary brain injury caused by ICH, little progress has been made treating the subsequent inflammatory cascade. Pre-clinical studies have made advancements identifying components of neuroinflammation, including microglia, astrocytes, and T lymphocytes. After cerebral insult, inflammation is initially driven by the M1 microglia, secreting cytokines (e.g., interleukin-1β [IL-1β] and tumor necrosis factor-α) that are involved in the breakdown of the extracellular matrix, cellular integrity, and the blood brain barrier. Additionally, inflammatory factors recruit and induce differentiation of A1 reactive astrocytes and T helper 1 (Th1) cells, which contribute to the secretion of inflammatory cytokines, augmenting M1 polarization and potentiating inflammation. Within 7 days of ICH ictus, the M1 phenotype coverts to a M2 phenotype, key for hematoma removal, tissue healing, and overall resolution of inflammation. The secretion of anti-inflammatory cytokines (e.g., IL-4, IL-10) can drive Th2 cell differentiation. M2 polarization is maintained by the secretion of additional anti-inflammatory cytokines by the Th2 cells, suppressing M1 and Th1 phenotypes. Elucidating the timing and trigger of the anti-inflammatory phenotype may be integral in improving clinical outcomes. A challenge in current translational research is the absence of an equivalent disease animal model mirroring the patient population and comorbid pathophysiologic state. We review existing data and describe potential therapeutic targets around which we are creating a bench to bedside translational research model that better reflects the pathophysiology of ICH patients.

Mechanisms and Therapeutic Targets of Depression after Intracerebral Hemorrhage

Remote Diffusion-Weighted Imaging Lesions in Intracerebral Hemorrhage: Characteristics, Mechanisms, Outcomes, and Therapeutic Implications

Systematic Hypothesis for Post-Stroke Depression Caused Inflammation and Neurotransmission and Resultant on Possible Treatments.

MicroRNAs Modulate Neuroinflammation after Intracerebral Hemorrhage: Prospects for New Therapy.

Pathophysiological Mechanisms and Potential Therapeutic Targets in Intracerebral Hemorrhage

Emerging therapeutic targets associated with the immune system in patients with intracerebral haemorrhage (ICH): From mechanisms to translation

Mechanisms and potential therapeutic targets for spontaneous intracerebral hemorrhage

Pathological Mechanism and Drug Therapy for Post Stroke Depression

Mechanism and application of immune interventions in intracerebral haemorrhage

Potential therapeutic targets for intracerebral hemorrhage-associated inflammation: An update

Role and mechanisms of cytokines in the secondary brain injury after intracerebral hemorrhage

The hallmark and crosstalk of immune cells after intracerebral hemorrhage: Immunotherapy perspectives

Investigating the Potential Mechanisms and Therapeutic Targets of Inflammatory Cytokines in Post-stroke Depression

Neuroinflammation after Intracerebral Hemorrhage and Potential Therapeutic Targets

Serum Cholesterol and Interleukin-10 Are Associated with Post-Intracerebral-hemorrhage Depression in Patients with Acute Primary Supratentorial Intracerebral Hemorrhage

Mitochondria: Novel Mechanisms and Therapeutic Targets for Secondary Brain Injury After Intracerebral Hemorrhage

Mechanism and therapeutic strategies of depression after myocardial infarction

Recent Advance in Endoplasmic Reticulum Stress -Mediated Inflammatory Response after Intracerebral Hemorrhage

Immune-mediated disruption of the blood-brain barrier after intracerebral hemorrhage: Insights and potential therapeutic targets

Mechanism and Therapy of Brain Edema after Intracerebral Hemorrhage.

Treatment of Intracerebral Hemorrhage: Current Approaches and Future Directions